Legal & General Group
MANE

Legal & General Group’s Veradermics Inc MANE Stock Holding History

Legal & General Group’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$449K Buy
+7,105
New +$358K ﹤0.01% 2380

Other funds holding MANE

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Legal & General Group's MANE Position: Q1 2026 in Review

Legal & General Group opened a new position in Veradermics Inc (MANE) in Q1 2026: 7,105 shares worth $449K. The stake represents ﹤0.01% of the portfolio and ranks #2380 among its holdings.

81 funds tracked by Wall St. Rank hold MANE as of Q1 2026.

  • Legal & General Group held 7,105 shares of Veradermics Inc worth $449K as of Q1 2026.
  • Veradermics Inc was a new Legal & General Group position in Q1 2026.
  • Veradermics Inc made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2380 holding.
  • 81 funds tracked by Wall St. Rank held Veradermics Inc as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.